Chengdu Kanghong Pharmaceutical Group Co.,Ltd.

About Chengdu Kanghong Pharmaceutical Group Co.,Ltd.

Chengdu Kanghong Pharmaceutical Group Co., Ltd. (Kanghong Pharmaceutical) is a pharmaceutical group dedicated to the research and development, production, sales, and after-sales service of traditional Chinese medicines, chemical drugs, and biological products. Headquartered in Chengdu, Sichuan Province, the company has over 4,000 employees and possesses production bases for traditional Chinese medicines, chemical drugs, and biological products, with a sales network covering the entire country. Since its establishment, Kanghong Pharmaceutical has received care and guidance from all levels of government and widespread attention from all sectors of society. In 2008, in the first national pharmaceutical enterprise credit evaluation organized by the China Association for Pharmaceutical Commerce under the entrustment of the Ministry of Commerce, Kanghong Pharmaceutical became one of the only seven pharmaceutical enterprises nationwide to receive an "AAA credit rating," and also the only accredited enterprise in Sichuan Province. In 2012, it was once again rated as an "AAA credit rating" enterprise. In 2009, the "" trademark of Kanghong Pharmaceutical was recognized as a "China Well-known Trademark" by the State Administration for Industry and Commerce. In the same year, Kanghong Pharmaceutical won the "Innovation Award" for 30 Years of Reform and Opening Up in the "Top 30 Influential Figures in China's Pharmaceutical Industry" jointly awarded by the China Pharmaceutical Enterprise Management Association and Sohu.com. In 2010, it was listed as a "National Enterprise Intellectual Property Pilot Unit" by the State Intellectual Property Office. In 2011, it was rated as one of the "Top Ten Brands of Innovative Enterprises in China's Chemical Pharmaceutical Industry" by the China Chemical Industry Association. In 2012, it was included in the fifth batch of "National Innovative Pilot Enterprises" by the Ministry of Science and Technology, the State-owned Assets Supervision and Administration Commission of the State Council, and the All-China Federation of Trade Unions.